This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Group Limited. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Nicolas Bertheleme: Innovator in AMPA Receptor Potentiation
Introduction
Nicolas Bertheleme is a notable inventor based in Harlow, GB. He has made significant contributions to the field of medicine through his innovative research and development of compounds that potentiate the AMPA receptor. His work is particularly relevant in addressing conditions related to glutamate receptor function.
Latest Patents
Bertheleme holds a patent for "Compounds which potentiate the AMPA receptor and uses thereof in medicine." This patent includes compounds of formula (I) and their salts, where specific variables and groups are defined. The patent outlines processes for preparation, pharmaceutical compositions, and their applications as medicaments, particularly in treating diseases such as schizophrenia and cognitive impairment.
Career Highlights
Nicolas Bertheleme is associated with Glaxo Group Limited, where he has been instrumental in advancing research related to AMPA receptor modulation. His work has the potential to impact therapeutic strategies for various neurological conditions.
Collaborations
Bertheleme has collaborated with notable colleagues, including Wai Ngor Chan and Jaqueline Sandra Scott, contributing to a dynamic research environment focused on innovative medical solutions.
Conclusion
Nicolas Bertheleme's contributions to the field of medicine through his patent on AMPA receptor potentiation highlight his role as an influential inventor. His work continues to pave the way for advancements in treating neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile